OpiCapone Effect on Motor Fluctuations and pAiN

Summary

The aim of this study is to investigate the efficacy of 50 mg opicapone when administered with the existing treatment of levodopa (L-dopa) plus a dopa decarboxylase inhibitor (DDCI), in Parkinson's disease (PD) patients with end-of-dose motor fluctuations and associated pain

Timeline

Start

2021-02-25

Primary completion

2024-02-16

Completion

2024-02-16

Drugs

Indications